REGENERON PHARMACEUTICALS, INC. (REGN) Current Reports & Earnings Releases
Upcoming
- 2026-10-27 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-07-30 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-07-06 | 8-K | Results of Operations | SEC |
| 2026-06-17 | 8-K | Shareholder Vote Results | SEC |
| 2026-04-29 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-04-08 | 8-K | Results of Operations | SEC |
| 2026-01-30 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-01-12 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-10-28 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-10-06 | 8-K | Results of Operations | SEC |
| 2025-08-01 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-06-18 | 8-K | Shareholder Vote Results | SEC |
| 2025-04-29 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-02-04 | 8-K | Results of Operations, Other Events, Financial Statements & Exhibits | SEC |
| 2025-01-13 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-10-31 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-10-07 | 8-K | Results of Operations | SEC |
| 2024-08-01 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-07-08 | 8-K | Results of Operations | SEC |
| 2024-06-20 | 8-K | Shareholder Vote Results | SEC |
| 2024-05-02 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-02-02 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-01-31 | 8-K | Officer / Director Changes | SEC |
| 2024-01-08 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.